A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (12) , 2077-2087
- https://doi.org/10.1016/s0149-2918(02)80098-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEuropean Respiratory Journal, 1996
- Exercise-Induced Bronchospasm in Children: Effects and TherapiesPediatric Annals, 1996
- Efficacy and Duration of Salmeterol Powder Inhalation in Protecting Against Exercise-Induced BronchoconstrictionAnnals of Allergy, Asthma & Immunology, 1996
- Long-Acting Inhaled Beta AgonistsJournal of Asthma, 1995
- Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.American Journal of Respiratory and Critical Care Medicine, 1994
- Rapid Onset of Action of Inhaled Formoterol in Asthmatic PatientsChest, 1992
- Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in childrenJournal of Allergy and Clinical Immunology, 1992
- Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting β2-adrenergic agonistRespiratory Medicine, 1990
- Issues in exercise-induced asthmaJournal of Allergy and Clinical Immunology, 1985
- Refractory Period after Hyperventilation-induced Asthma1,2American Review of Respiratory Disease, 1983